(Q43662476)

25 November 2017

title

Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine (English)

1 reference

25 November 2017

M Narita

1

1 reference

25 November 2017

K Yoshizawa

2

1 reference

25 November 2017

M Nomura

3

1 reference

25 November 2017

K Aoki

4

1 reference

25 November 2017

T Suzuki

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

423

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

41-46

1 reference

The NMDA antagonist model for schizophrenia: promise and pitfalls.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Effects of atypical antipsychotic agents on social behavior in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Neurobiology. Taking apart NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Molecular diversity of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Neuronal mechanisms of ketamine-induced anesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Structure and function of the NMDA receptor channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Interactions between H1-antagonists and opioids: a drug discrimination study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNAs in the forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901089-5

10.1016/S0014-2999(01)01089-5

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference